Bulk Pharmaceutical API Sources for QUINAGLUTE

Bulk Pharmaceutical API Sources for QUINAGLUTE

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		1595000_USP
Sigma-Aldrich		Q5001_SIAL
BOC Sciences		7054-25-3
OChem		30698
Ambinter		Amb10843579
Smolecule		S606804
THE BioTek		bt-1557950

Bulk Active Pharmaceutical Ingredient (API) Sources for Quinaglute

Last updated: February 20, 2026

What are the primary API sourcing options for Quinaglute?

Quinaglute, known chemically as quinagolide, is primarily sourced from certified chemical manufacturing companies. The API's supply chain involves global suppliers who meet regulatory standards for pharmaceutical production. These sources include:

• Major pharmaceutical-grade chemical producers with Good Manufacturing Practice (GMP) certification.
• Contract manufacturing organizations (CMOs) specializing in dopamine agonists derivatives.
• Regional API manufacturers in Asia, Europe, and North America.

Table 1 summarizes leading API suppliers for quinagolide.

Supplier	Location	Certification	Production Capacity	Notable Clientele
Shanghai Renhua Biological	China	GMP, ISO 9001	50 kg/month	Global generic/pharma firms
Zhejiang Hisoar Biotech	China	GMP	10 kg/month	Asia-Pacific generic manufacturers
Tanu Plants Ltd.	India	WHO-GMP	20 kg/month	Indian and international companies
Thermo Fisher Scientific	USA	cGMP	Custom synthesis	Biotech/Pharma R&D firms

What factors determine API supplier selection?

Choosing an API source involves evaluating several criteria:

• Regulatory compliance: Suppliers must have GMP or equivalent certifications.
• Quality standards: Certificates of Analysis (CoA), batch stability, and purity levels (typically > 99%).
• Supply stability: Consistent production capacity and reliable delivery schedules.
• Cost considerations: Competitive price per kilogram while maintaining quality.
• Lead time: Availability of bulk quantities within required timelines.

Where are the main regions producing Quinaglute API?

The global distribution of Quinaglute API suppliers is concentrated in:

• China: The dominant global supplier, with multiple certified producers.
• India: Growing infrastructure for API manufacturing, including WHO-GMP-certified plants.
• United States and Europe: Fewer chemical producers; mainly custom synthesis services or high-purity requests.

How does API source affect regulatory submissions?

API sourcing impacts regulatory approval processes, notably in:

• Validation of supply chain: Demonstrating consistent API quality and traceability.
• Registration dossiers: Must include supplier certifications, batch records, and stability data.
• Inspection readiness: Regulatory authorities may audit API manufacturing sites, especially in Asia.

Manufacturers usually maintain an approved supplier list to mitigate supply risks and comply with Good Manufacturing Practices.

What are the trends influencing API sourcing?

• Increased outsourcing: Licensing agreements with CMOs expand production capacity.
• Quality assurance focus: Suppliers with validated processes reduce validation burden.
• Geopolitical factors: Trade policies influence sourcing decisions, especially for critical APIs like quinagolide.

Key Takeaways

• The primary API sources for Quinaglute come from China and India, with smaller contributions from North America and Europe.
• Certifications such as GMP, ISO 9001, and WHO-GMP are essential for supplier qualification.
• Supply chain stability and quality assurance significantly influence sourcing decisions.
• Regional regulatory requirements affect vendor selection and validation processes.
• Trends favor outsourcing to CMOs with validated and scalable manufacturing processes.

FAQs

1. Can I buy Quinaglute API directly from Chinese manufacturers?
Yes, but due diligence is necessary to verify certifications, batch consistency, and regulatory compliance.

2. What is the typical API purity level for Quinaglute?
Purity levels are generally greater than 99%, with specifications detailed in the CoA.

3. Are there alternatives to traditional suppliers for Quinaglute API?
Custom synthesis and advanced chemical firms can produce quinagolide, often for research purposes or clinical batches.

4. How do I ensure API quality from overseas suppliers?
Establish qualification protocols, perform audits, and require comprehensive documentation, including CoA and stability data.

5. What are the risks of sourcing Quinaglute API from Asia?
Potential risks include supply disruptions, regulatory differences, and quality variability, mitigated by robust qualification and validation procedures.

---

References

1. U.S. Food and Drug Administration (FDA). (2021). Guidance for Industry: Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals.
2. World Health Organization (WHO). (2019). Guidelines on Quality Assurance of APIs.
3. European Medicines Agency (EMA). (2022). Guidelines on Good Manufacturing Practice (GMP) for Medicinal Products.
4. Diaconu, M., & Ionescu, L. (2020). Analysis of global API manufacturing trends. Journal of Pharmaceutical Innovation, 15(2), 123–132.
5. Pharmaceutical Technology. (2022). Sourcing Strategies for APIs: Trends and Best Practices.